This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Only when you have a clear idea of those three factors can you decide whether or not to take a medication to lower your LDL cholesterol. I use statins in the question posed above because that is what most people think and, in fact, what they will start with when looking to lower their LDL cholesterol with a medication. Not zero risk.
Excess cholesterol is known to form artery-clogging plaques that can lead to stroke, arterial disease, heart attack, and more, making it the focus of many heart health campaigns. But what if there's more to the picture than just cholesterol?
“Cholesterol does not cause heart disease.“ “Cholesterol doesn’t cause heart disease” The argument goes like this. “If cholesterol causes heart disease, why is it that about half of all patients with a heart attack have normal cholesterol? Cholesterol is an essential part of the story.
Atherosclerosis, or the buildup of plaque in the arteries, develops when low-density lipoprotein cholesterol (LDL-C) enters the blood vessel walls through dysfunctional endothelial cells (EC), leading to the formation of plaques.
(MedPage Today) -- Year-to-year fluctuations in total cholesterol and low-density lipoprotein cholesterol (LDL-C) levels were tied to higher risks of cognitive decline and dementia, a study of nearly 10,000 older adults showed. Participants with.
High cholesterol is a core to heart disease development and can usually be easily managed. That’s why I’m hosting The Cholesterol Secrets Masterclass —a live, 1-hour webinar where I’ll share the exact strategies I use with my patients to help them lower their cholesterol and protect their heart health.
The coffee from most of the coffee machines in workplaces contains relatively high levels of cholesterol-elevating substances. There is a big difference in comparison to coffee made in regular paper filter coffee makers, which filter out most of these substances.
Nature Reviews Cardiology, Published online: 18 November 2024; doi:10.1038/s41569-024-01100-3 Cholesterol crystals (CCs) have a pathogenic role in various cardiovascular diseases, particularly atherosclerosis.
As a cardiologist with over 20 of experience, I’ve seen how confusing and overwhelming it can be for people to manage their cholesterol. ” While these recommendations can help, they don’t address the root causes of high cholesterol. And they certainly don’t give you a clear, step-by-step plan to follow.
(MedPage Today) -- Higher levels of high-density lipoprotein cholesterol (HDL-C) were associated with an increased risk of glaucoma, while high levels of low-density lipoprotein cholesterol (LDL-C), total cholesterol, and triglycerides were associated.
Non-HDL Cholesterol There is no ‘Good’ cholesterol on a standard cholesterol blood test. There really is only bad cholesterol. The relationship is simple—higher cholesterol for longer increases your risk of coronary artery disease 4. A 40-year-old male with a Non-HDL cholesterol of 5.0
BackgroundEmerging genetic and observational evidence indicates that remnant cholesterol (RC) is a significant residual risk factor for cardiovascular diseases. Our study also examined the relationship between inconsistencies in RC and non-high-density lipoprotein cholesterol (non-HDL-C) levels and the severity of coronary artery stenosis.
(MedPage Today) -- ATLANTA -- A novel PCSK9 inhibitor safely reduced LDL cholesterol levels with just a single, quick, once-monthly dose, the phase III LIBerate-HR trial showed. Lerodalcibep reduced LDL cholesterol by 56% more than placebo from.
government's premier research body has made an important discovery that could help create new drugs to lower "bad" cholesterol, and hopefully prevent heart attacks and stroke.
milla1cf Sun, 04/07/2024 - 18:09 April 7, 2024 — Among patients at high or very high risk for a heart attack or stroke, the addition of the investigational drug lerodalcibep to standard cholesterol-lowering medication for one year reduced LDL, or “bad” cholesterol, levels by more than half on average, compared with a placebo.
Scientists have made a significant breakthrough in understanding how 'bad' cholesterol, known as low-density lipoprotein-cholesterol or LDL-C, builds up in the body.
indicates that cholesterol levels that fluctuate significantly from year to year without a change in medication may someday help to identify those with a higher risk of developing. Research Highlights: A study of older adults in Australia and the U.S.
More than 70% of American Indian young adults aged 20-39 and 50% of American Indian teens have cholesterol levels or elevated fat in the blood that put them at risk for cardiovascular disease, a new study suggests.
adults have high cholesterol, according to the Centers for Disease Control and Prevention (CDC). Untreated, high cholesterol can lead to heart disease and stroke, which are two of the top causes of death in the U.S. Nearly two in five U.S.
Researchers have discovered that certain components of so-called 'good' cholesterol -- high-density lipoproteins (HDL) -- may be associated with an increased prevalence of cardiovascular disease.
National Institute of Health (NIH) scientists have made a significant breakthrough in understanding how "bad" cholesterol, known as low-density lipoprotein-cholesterol or LDL-C, builds up in the body.
tribal communities found that high cholesterol was twice as prevalent among American Indian adolescents and young adults compared to the overall U.S. Research Highlights: A study of more than 1,400 people in U.S. population. The study also noted that.
The app also recorded other significant heart health risk factors, such as cholesterol, weight, and physical activity via integration with external sources including electronic medical records and fitness trackers. Change in blood pressure (BP), LDL cholesterol, and weight were evaluated from baseline to follow up.
This pooled cohort study assesses the risk of coronary heart disease associated with familial hypercholesterolemia variants in individuals with moderately to severely elevated low-density lipoprotein cholesterol.
milla1cf Sat, 04/06/2024 - 18:32 April 6, 2024 — The first trial of a novel strategy for removing cholesterol from patients’ arteries did not reduce the risk of death, heart attack or stroke within three months of a prior heart attack, according to research presented at the American College of Cardiology ’s Annual Scientific Session.
Niacin , a common B vitamin once recommended to patients as a way to help lower cholesterol, has been linked to cardiovascular disease, Cleveland Clinic researchers announced Feb.
Our risk of developing atherosclerosis -- 'furring' of the arteries -- can begin much earlier in life than was previously thought, highlighting the need to keep cholesterol levels low even when we are young, new research has discovered.
(MedPage Today) -- Recently, a cardiologist published a commentary in Medscape arguing that physicians and scientists who challenge the putative clinical benefit of statin medications are pseudoscientists. He claimed, ".somewhere somewhere along the way.
The prevalence of high total cholesterol was 11.3% adults from August 2021 to August 2023, according to a November data brief published by the National Center for Health Statistics.
To mitigate misinterpretations of cardiovascular risk factors, we propose the use of the lipid triad components to define dyslipidemia: LDL-cholesterol >3.0mmol/L for primary prevention and >2.6mmol/L or >1.4mmol/L for secondary prevention in patients over/under 75 years old, respectively; or HDL-cholesterol 1.7mmol/L.
A new study reveals that immune cells in the liver react to high cholesterol levels and eat up excess cholesterol that can otherwise cause damage to arteries. The findings suggest that the response to the onset of atherosclerosis begins in the liver.
BackgroundLow-Density Lipoprotein Cholesterol (LDL-C) is the primary lipid therapy target for coronary artery disease (CAD) patients after percutaneous coronary intervention (PCI). Employing Multivariate Cox regression analysis, we assessed the correlation between RLP-C and NTLs progression.
The Defining Risk module includes lessons on: Defining Metabolic Health Cholesterol Principles Understanding Your Cholesterol Panel Advanced Cholesterol Testing Lipoprotein (a) - Lp(a) Insulin Resistance Metabolic Syndrome Pre-Diabetes & Diabetes Assessing Visceral Fat How To Measure Fitness The Importance of Muscle Metrics.
The RNA inhibitor olpasiran significantly reduces a type of "bad cholesterol" that's associated with a high risk of cardiovascular events, according to results from an analysis by a Mount Sinai researcher of a Phase II trial.
The Defining Risk module includes lessons on: Defining Metabolic Health Cholesterol Principles Understanding Your Cholesterol Panel Advanced Cholesterol Testing Lipoprotein (a) - Lp(a) Insulin Resistance Metabolic Syndrome Pre-Diabetes & Diabetes Assessing Visceral Fat How To Measure Fitness The Importance of Muscle Metrics.
This systematic review and individual patient data meta-analysis investigates the association of an alternative low-density lipoprotein (LDL) strategy with differences in long-term efficacy and safety in patients with atherosclerotic cardiovascular disease (ASCVD) compared with a high-intensity statin strategy.
Measurement of low-density lipoprotein cholesterol, high-sensitivity C-reactive protein, and lipoprotein(a) predicted the 30-year cardiovascular disease risk among women enrolled in the Women’s Health Study.
Nature Reviews Cardiology, Published online: 18 October 2024; doi:10.1038/s41569-024-01095-x Consumption of a high-fat diet leads to the progressive growth of atherosclerotic lesions.
Houston Methodist researchers have discovered that certain components of so-called "good" cholesterolhigh-density lipoproteins (HDL)may be associated with an increased prevalence of cardiovascular disease.
Douglas Weaver and Kausik Ray delve into the importance of individualized cholesterol management. In this interview, Drs. They discuss the latest research, the benefits of aggressive LDL reduction, and how tailoring treatment plans can help optimize heart health while minimizing risks.
There is no correlation between high-density lipoprotein cholesterol (HDL-C) levels and a patient's risk for developing movement disorders while taking an antipsychotic, according to a study published in the April-June issue of Innovations in Clinical Neuroscience.
Reduction in low-density lipoprotein cholesterol (LDL-C) levels has consistently demonstrated a reduced risk of atherosclerotic cardiovascular disease (ASCVD). There is extensive evidence from randomized trials that demonstrates the effectiveness of lipid-lowering agents in reducing ASCVD-related events.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content